Interactive demonstration of CALEX® Cap extraction and quantitative fecal calprotectin measurement using the Quantum Blue® fCAL rapid test technology.
BÜHLMANN Quantum Blue® Therapeutic Drug Monitoring Tutorial: Demonstration of quantitative trough
A Report of A. Suter* and Dr. C. Fuhrer** from SYNLAB
A Report of Martina Kobelt* and Karin Jung**, Zentrum für Labormedizin,
Unilabs Portugal, a private European lab chain, made a comprehensive evaluation
Faecal Calprotectin is a new biomarker which is helping to save money for the NHS by preventing unnecessary procedures on patients by screening out patients with IBS who do not require endoscopies.
The symptoms of functional disorders such as Irritable Bowel Syndrome (IBS) and organic inflammatory intestinal disease (IBD) can be very similar in presentation but are two very different medical conditions.
The New Faecal Calprotectin Care Pathway | NICE February 1, 2019
Big Changes Coming Soon to a Clinic Near You March 9, 2018
Launch of IBD Toolkit for GPs November 28, 2017